Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
6.2.2024
0:00
12:13
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents.
Related Content:
Flere episoder fra "Coronavirus (COVID-19) Q&A"
Gå ikke glip af nogen episoder af “Coronavirus (COVID-19) Q&A” - abonnér på podcasten med gratisapp GetPodcast.